Common Baldness Drug Could Reduce Prostate Cancer Risk, University of Texas Health Science Center Study

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A drug used to treat enlarged prostate and male pattern baldness also reduces a man’s risk of prostate cancer by nearly a third, according to a large new study. The findings on nearly 19,000 men also overturn earlier concerns that treatment with finasteride -- the agent in the prostate drug Proscar and the hair-loss drug Propecia -- might promote the development of more virulent prostate cancers in men who contract the disease, researchers said.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC